
Rightview builds AI operations software that answers clinical-trial staff questions from study documents and automates drug-development workflows.
Rightview pairs its software with in-house staff who have worked in drug development, and it builds workflows around each customer's existing process rather than requiring teams to adopt a fixed product. Deployment needs no site-level IT integration, so a network can roll out study documents to every site at once.
The platform is built for regulated work, with immutable audit logs, e-signature support, and validation documentation. Customer queries are never used to train AI models, third-party AI vendors operate under zero data retention, and outputs are structured for use by other AI agents through MCP.
Source: rightview.ai
Rightview prices each deployment by organization size, number of studies, and compliance requirements, and offers Team, Growth, and Enterprise plans with custom quotes. Prospects start with a guided demo on their own use case, followed by a scoped pilot before committing.
The Team plan covers a single site or research team with up to 10 users. Growth adds unlimited users and studies, REST API and MCP access, and SSO, while Enterprise adds a 21 CFR Part 11 validation package, IQ/OQ/PQ documentation, a dedicated environment, and forward-deployed engineering.
Source: rightview.ai
Site Navigator gives clinical research site staff cited answers drawn from protocols, amendments, investigator brochures, lab manuals, informed consent forms, and other study documents. Each answer links to the exact source page, and questions can route to custom escalations and workflows.
The product logs every question and answer for audit purposes and tracks delegation logs and training compliance per site. Network leaders and sponsors see which questions recur across sites and can combine that view with signals from EDC, CTMS, EHR, and reporting systems.
Source: rightview.site